文献
J-GLOBAL ID:202002276220834775
整理番号:20A1717555
ダカルバジン治療による間欠後のプログラム細胞死1阻害剤の再挑戦は進行性悪性黒色腫に有効である
Rechallenge of programmed cell death 1 inhibitor after an interval with dacarbazine treatment may be effective for advanced malignant melanoma
著者 (6件):
Kan Takanobu
(Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Takahagi Shunsuke
(Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Kawai Mikio
(Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Matsubara Daiki
(Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Tanaka Akio
(Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Hide Michihiro
(Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
資料名:
Journal of Dermatology
(Journal of Dermatology)
巻:
47
号:
8
ページ:
907-910
発行年:
2020年08月
JST資料番号:
W1578A
ISSN:
0385-2407
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オーストラリア (AUS)
言語:
英語 (EN)